What's in Tigenix S.A.U.'s pipeline?

Tigenix S.A.U. has 6 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 2 in Phase 2, 1 in Phase 1.

Which companies overlap with Tigenix S.A.U.'s portfolio?

Top competitors by shared drug class: Ain Shams Maternity Hospital, Anterogen Co., Ltd., Cell Biopeutics Resources Sdn Bhd, Gary A Levy, O. Ont. MD. FRCP AGAF, Gwo Xi Stem Cell Applied Technology Co., Ltd..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/tigenix-s-a-u.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Tigenix S.A.U. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tigenix S.A.U. pipeline: 0 marketed, 0 filed, 3 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 2 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Cx601	Cx601	phase 3	Allogeneic mesenchymal stem cell therapy		Gastroenterology / Immunology
ASCs (Cx401, company code)	ASCs (Cx401, company code)	phase 3	Allogeneic mesenchymal stem cell therapy		Dermatology / Wound Care
Fibrin adhesive	Fibrin adhesive	phase 3	Hemostatic agent / Tissue adhesive	Fibrinogen / Thrombin pathway	Surgery / Hemostasis

Therapeutic area mix

Dermatology / Wound Care · 1
Gastroenterology / Immunology · 1
Muscular Dystrophy · 1
Regenerative medicine · 1
Surgery / Hemostasis · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams Maternity Hospital · 1 shared drug class
Anterogen Co., Ltd. · 1 shared drug class
Cell Biopeutics Resources Sdn Bhd · 1 shared drug class
Gary A Levy, O. Ont. MD. FRCP AGAF · 1 shared drug class
Gwo Xi Stem Cell Applied Technology Co., Ltd. · 1 shared drug class
Kang Stem Biotech Co., Ltd. · 1 shared drug class
Manipal Acunova Ltd. · 1 shared drug class
Medipost, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Tigenix S.A.U.:

Cite this brief

Drug Landscape (2026). Tigenix S.A.U. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/tigenix-s-a-u. Accessed 2026-06-09.